Why Can’t We Find New Antibiotics?

This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below. View on YouTube

This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below. View on YouTube

Antibiotics save millions of lives, but bacteria are constantly evolving to beat the drugs we use to fight them. 

Eventually, bacteria may become resistant to every form of antibiotic we have. That’s why finding new antibiotics is so important, but serious scientific barriers stand in the way. 

See the challenges that scientists face in their search for new antibiotics—and what we can do to overcome them.

Learn more about antibiotic resistance here: Antibiotic Resistance Project.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Podcast

The Fight Against Antibiotic Resistance

Quick View
Podcast

Nearly a century after Alexander Fleming’s discovery of penicillin, bacteria continue to develop the ability to defeat antibiotics. Doctors worldwide are concerned about the spread of superbugs that are resistant to all antibiotics. Host Dan LeDuc visits Fleming’s London lab for some history and talks with Pew’s Allan Coukell about current efforts to reduce unnecessary use of these drugs and encourage development of new ones.

Report

A Scientific Roadmap for Antibiotics

Quick View
Report

In recent decades, the discovery and development of new antibiotics have slowed dramatically as scientific barriers to drug discovery, regulatory challenges, and diminishing returns on investment have led major drug companies to scale back or abandon their antibiotic research.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.